Directors Deals 

Softcat MD sells down

Softcat MD sells down

A third-quarter update from Softcat (SCT) revealed that it had achieved growth in revenue, gross profit and operating profit, with cash receipts broadly in line with normal trends. But management flagged a high degree of uncertainty in the months ahead and that the group is by no means immune to the challenges in the wider economy. 

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now